PDF: Granny Storm Crow’s MMJ Reference List
Well, here I am again, staring at this blank screen, trying to figure out what to say so you will share the information I have gathered. ―Once the medical facts about cannabis become known, the need for legalization decriminalization becomes obvious! How many times have I said that? I need YOU to educate those around you. I can‘t do it alone!
INDEX
Introduction……………………………………………………………………………………………………1
ACEA/ ARACHIDONYL-2′-CHLOROETHYLAMIDE……………………………………….. 2
ACHILLES TENDINOSIS……………………………………………………………………….4
ACNE………………………………………………………………………………………………4
ADD/ ADHD…………………………………………………………………………………………………..4
ADDICTION…………………………………………………………………………………………………..6
2-AG /2-ARACHIDONOYLGLYCEROL……………………………………………………….8
2-AGE/ 2-ARACHIDONYL GLYCERYL ETHER/ NOLADIN ETHER……………….17
AGING/ USE BY SENIORS ……………………………………………………………………………………18
AIDS – see HIV
AJULEMIC ACID………………………………………………………………………………………….21
ALCOHOLISM………………………………………………………………………………………………22
ALLERGIES AND CANNABIS………………………………………………………………………26
ALLERGIES TO CANNABIS…………………………………………………………………..27
ALS / AMYOTROPHIC LATERAL SCLEROSIS…………………………………………….28
ALZHEIMER’S DISEASE………………………………………………………………………………30
AM- 251…………………………………………………………………………………………………………36
AM-281…………………………………………………………………………………………..40
AM-404…………………………………………………………………………………………………….41
AM-630…………………………………………………………………………………………………….42
AM-694…………………………………………………………………………………………..43
AM-1241………………………………………………………………………………………………………..43
AM-1346………………………………………………………………………………………………………..44
AM-1710…………………………………………………………………………………………45
AM-2233………………………………………………………………………………………….45
AM- 4054………………………………………………………………………………………………………45
AM- 4113………………………………………………………………………………………………………46
AM 6545………………………………………………………………………………………….46
AMOTIVATIONAL SYNDROME………………………………………………………………….46
ANANDAMIDE……………………………………………………………………………………………47
ANECDOTAL / PERSONAL STORIES…………………………………………………………..65
ANOREXIA NERVOSA – also see APPETITE STIMULANT ………………………..66
ANTI-BACTERIAL PROPERTIES…………………………………………………………………68
ANTI-FUNGAL PROPERTIES………………………………………………………………………69
ANTI-INFLAMMATORY PROPERTIES………………………………………………………..69
ANTIMICROBIAL PROPERTIES………………………………………………………………76
ANTIOXIDANT PROPERTIES……………………………………………………………………….77
ANXIOLYTIC EFFECTS…………………………………………………………………………………78
APPETITE STIMULANT………………………………………………………………………………..82
ARACHIDONYL-2′-CHLOROETHYLAMIDE- see ACEA
2-ARACHIDONOYLGLYCEROL – see 2-AG
ARTHRITIS…………………………………………………………………………………………………….90
AS- 1535907……………………………………………………………………………………..93
AS-1907417………………………………………………………………………………………94
673ASTHMA…………………………………………………………………………………………………..94
ATHEROSCLEROSIS……………………………………………………………………………………….95
AUTISM………………………………………………………………………………………………………….97
BACK PAIN……………………………………………………………………………………………………..99
BETA-CARYOPHYLENE/ (E)-BCP……………………………………………………………………99
BIPOLAR DISORDER…………………………………………………………………………………………………100
BLADDER/ URINARY FUNCTIONS……………………………………………………………………………100
BLEPHAROSPASM…………………………………………………………………………………………………….100
BLOOD……………………………………………………………………………………………………………………….100
BLOOD PRESSURE…………………………………………………………………………………………………….103
BONES- see OSTEOPOROSIS
BONE MARROW……………………………………………………………………………………………………106
BOWEL DISORDERS – also see GERD, COLITIS …………………………………………………..106
BRAIN CELLS- see NEURONS
BRAIN- PHYSICAL EFFECTS…………………………………………………………………………………….115
BRAIN TRAUMA………………………………………………………………………………………………………..117
BREASTFEEDING/ INFANT APPETITE…………………………………………………………………….119
BULIMIA…………………………………………………………………………………….120
CANCER – BASAL CELL CARCINOMA – see CANCER – SKIN
CANCER – BLADDER / URETHRAL………………………………………………………..121
CANCER- BONE…………………………………………………………………………………………………………121
CANCER- BREAST……………………………………………………………………………………………………..122
CANCER- CERVICAL…………………………………………………………………………………………………125
CANCER- CHEMOTHERAPY- see CHEMOTHERAPY
CANCER- CHOLANGIOCARCINOMA………………………………………………………………………..126
CANCER- COLON /COLORECTAL……………………………………………………………………………..127
CANCER – ENDOMETRIAL………………………………………………………………….129
CANCER- GASTRIC……………………………………………………………………………………………………129
CANCER- GLIOMA……………………………………………………………………………………………………130
CANCER- HEAD AND NECK……………………………………………………………………………………..135
CANCER- KAPOSI’S SARCOMA………………………………………………………………………………..135
CANCER – KIDNEY………………………………………………………………………….136
CANCER- LEUKEMIA……………………………………………………………………………………………….136
CANCER – LIVER…………………………………………………………………………….137
CANCER- LUNG………………………………………………………………………………………………………..138
CANCER- LYMPHOMA……………………………………………………………………………………………..141
CANCER- MELANOMA……………………………………………………………………………………………..142
CANCER – NEUROBLASTOMA………………………………………………………………………………….143
CANCER- ORAL…………………………………………………………………………………………………………144
CANCER- OVARIAN…………………………………………………………………………………………………..145
674CANCER- PANCREATIC……………………………………………………………………………………….145
CANCER- PITUITARY ADENOMA…………………………………………………………………………….146
CANCER – PNET / PRIMITIVE NEUROECTODERMAL TUMOR………………………..146
CANCER- PROSTATE…………………………………………………………………………………………………146
CANCER – RHABDOMYOSARCOMA…………………………………………………………………………148
CANCER- RISK CANNABIS VS TOBACCO………………………………………………………………..149
CANCER- SKIN…………………………………………………………………………………………………………..149
CANCER – SQUAMOUS CELL CARCINOMA………………………………………………150
CANCER- TESTICULAR……………………………………………………………………………………………..151
CANCER – THYMOMA……………………………………………………………………………………………….151
CANCER- THYROID…………………………………………………………………………………………………..151
CANCER- VARIOUS/ UNNAMED……………………………………………………………………………….152
CANNABICHROMENE……………………………………………………………………………………………….159
CANNABIDIOL/ CBD…………………………………………………………………………………………………160
CANNABIDIOLIC ACID………………………………………………………………………182
CANNABIGEROL / CBG……………………………………………………………………………………………..182
CANNABINOID HYPEREMESIS SYNDROME…………………………………………….184
CANNABINOID RECEPTORS – see ENDOCANNABINOID SYSTEM, CBRs
CANNABINOR…………………………………………………………………………………186
CANNADOR……………………………………………………………………………………………………………….186
CARDIOVASCULAR- see HEART DISEASE
CARPAL TUNNEL SYNDROME…………………………………………………………….187
CBR- CB 1 RECEPTORS-…………………………………………………………………………………………….187
CBR – CB 2 RECEPTORS………………………………………………………………………………………..205
CBR– GPR 40 RECEPTORS…………………………………………………………………….218
CBR – GPR 55/ CB 3 RECEPTORS……………………………………………………………………………….219
CBR – GPR109 RECEPTORS………………………………………………………………………………………..221
CBR – GPR 119 RECEPTORS………………………………………………………………………………………222
CELIAC DISEASE……………………………………………………………………………..222
CEREBRAL PALSY……………………………………………………………………………223
CESAMET- see NABILONE
CHEMICAL COMPOSITION……………………………………………………………………………………….223
CHEMOTHERAPY………………………………………………………………………………………………………231
CHILDREN/ YOUNG ADULTS……………………………………………………………………………………236
CHOLERA………………………………………………………………………………………243
CHOLESTEROL……………………………………………………………………………….244
CHRONIC FATIGUE SYNDRONE……………………………………………………………244
COGNATIVE EFFECTS- see IQ
COLITUS……………………………………………………………………………………….244
COPD/ LUNG FUNCTION…………………………………………………………………………………………..246
COUGH………………………………………………………………………………………………………………………247
COWPOX………………………………………………………………………………………248
CP- 47,497…………………………………………………………………………………………………………………..248
CP 50,556-1 / LEVONANTRADOL…………………………………………………………..250
CP- 55,940…………………………………………………………………………………………………………………..251
CROHN’S – see BOWEL DISORDERS
675CRUETZFELDT-JACOB DISEASE- see MAD COW DISEASE
CT-3 – also see AJULMIC ACID… …………………………………………………………………………….254
CYSTIC FIBROSIS………………………………………………………………………………………………………254
CYSTITIS……………………………………………………………………………………………………………………255
DENTISTRY – see TEETH
DEPRESSION……………………………………………………………………………………………………………..255
DERMATITIS……………………………………………………………………………………………………………..259
DEXANABINOL – see HU-211
DIABETES………………………………………………………………………………………………………………….261
DOWN‘S SYNDROME………………………………………………………………………..267
DRIVING AND CANNABIS…………………………………………………………………………………………267
DRONABINOL……………………………………………………………………………………………………………270
DRUG INTERACTIONS- see INTERACTIONS WITH OTHER DRUGS
DRUG TESTING…………………………………………………………………………………………………………274
DRUG TESTING – BLOOD………………………………………………………………………………………….277
DRUG TESTING – BREATH TEST…………………………………………………………..279
DRUG TESTING – HAIR……………………………………………………………………………………………..279
DRUG TESTING- OTHER……………………………………………………………………………………………281
DRUG TESTING – ORAL…………………………………………………………………………………………….282
DRUG TESTING – URINE……………………………………………………………………………………………283
DYSKINESIA…………………………………………………………………………………..288
DYSTONIA…………………………………………………………………………………………………………………289
ECZEMA……………………………………………………………………………………………………………………290
EDEMA…………………………………………………………………………………………………………… ……..291
EHLERS-DANLOS SYNDROME………………………………………………………………………………..291
ELMIRIC ACIDS………………………………………………………………………………………………………..291
ENCEPHALITUS………………………………………………………………………………………………………..292
ENCEPHALOMYELITIS/ EAE……………………………………………………………………………………292
ENDOCANNABINOIDS……………………………………………………………………………………………..293
ENDOCANNABINOID SYSTEM – also see CBRs ……………………………………………………..301
ENDOMETRIOSIS……………………………………………………………………………………………………..319
EPILEPSY…………………………………………………………………………………………………………………..319
FAMILIAL MEDITERRANEAN FEVER……………………………………………………………………..325
FERTILITY………………………………………………………………………………………………………………..325
FEVER/ TEMPERATURE CONTROL………………………………………………………………………….327
FIBROMYALGIA……………………………………………………………………………………………………….329
FLU / INFLUENZA……………………………………………………………………………………………………..331
676GATEWAY THEORY…………………………………………………………………………………………….331
GENDER-BASED DIFFERENCES……………………………………………………………………………….333
GERD/GASTRO-ESOPHAGEAL REFLUX DISEASE……………………………………………………336
GLAUCOMA………………………………………………………………………………………………………………336
GOUT…………………………………………………………………………………………..341
GRANULOMA…………………………………………………………………………………341
GRAVE’S DISEASE…………………………………………………………………………………………………….341
GWP- 42006…………………………………………………………………………………….342
GYNOCOLOGY AND OBSTETRICS…………………………………………………………………………..342
HAIR…………………………………………………………………………………………………………………………..343
HEADACHE – see MIGRAINE
HEARING also see TINNITUS ………………………………………………………………………………….344
HEART DISEASE/ CARDIOVASCULAR…………………………………………………………………….344
HEMORRHAGIC SHOCK……………………………………………………………………..353
HEPATITIS…………………………………………………………………………………………………………………353
HEREDITARY MULTIPLE EXTOSES……………………………………………………….355
HERPES VIRUS…………………………………………………………………………………………………………..355
HEXAHYDROCANNABINOLS……………………………………………………………………………………356
HICCUPS…………………………………………………………………………………………………………………….356
HISTORICAL STUDIES -PRE 1937………………………………………………………………………………357
HISTORY- ANCIENT USE…………………………………………………………………………………………..360
HISTORY-1937 TO PRESENT……………………………………………………………………………………..361
HIV / AIDS………………………………………………………………………………………………………………….365
HORMONES……………………………………………………………………………………………………………….369
HPV/ HUMAN PAPILLOMA VIRUS……………………………………………………………………………373
HU-210……………………………………………………………………………………………………………………….373
HU-211……………………………………………………………………………………………………………………….377
HU-308……………………………………………………………………………………………………………………….378
HU-310…………………………………………………………………………………………379
HU-320……………………………………………………………………………………………………………………….379
HU-331……………………………………………………………………………………………………………………….379
HU-910…………………………………………………………………………………………380
HUNTINGTON’S DISEASE…………………………………………………………………………………………380
HYPEREMESIS – see CANNABINOID HYPEREMESIS SYNDROME
HYSTERECTOMY………………………………………………………………………………………………………383
IBS – see BOWEL DISORDERS
IDIOPATHIC INTRACRANIAL HYPERTENSION……………………………………………………….384
IDRASIL………………………………………………………………………………………..384
677IMMUNE SYSTEM……………………………………………………………………………………………….384
INCONTINENCE – see BLADDER OVERACTIVITY
INDICATIONS AND CLINICAL USES…………………………………………………………………………387
INFLUENZA- see FLU
INJURIES – see WOUNDS/ INJURIES
INTERACTIONS WITH OTHER DRUGS……………………………………………………………………..388
31 – IP 751 see AJULEMIC ACID
ISSAC‘S SYNDROME/ ACQUIRED NEUROMYOTONIA…………………………………397
IQ/ MEMORY/ COGNATIVE EFFECTS……………………………………………………………………….397
JWH-015……………………………………………………………………………………………………………………..403
JWH-018……………………………………………………………………………………………………………………..405
JWH-073……………………………………………………………………………………………………………………..408
JWH-100 / AM -678……………………………………………………………………………409
JWH-133……………………………………………………………………………………………………………………..409
KIDNEYS……………………………………………………………………………………………………………………412
KNOCK-OUT MICE………………………………… ………………………………………413
LEGIONAIRES DISEASE……………………………………………………………………..415
LEISHMANIASIS………………………………………………………………………………………………………..416
LIVER – NON HEPATITIS……………………………………………………………………………………………416
LONG TERM USE EFFECTS……………………………………………………………………………………….421
LUNG FUNCTION………………………………………………………………………………………………………423
LUPUS………………………………………………………………………………………………………………………..424
LYME DISEASE……………………………………………………………………………….425
MACULAR DEGENERATION………………………………………………………………..425
MAD COW/ CRUETZFELDT-JACOB DISEASE…………………………………………………………..425
MARINOL………………………………………………………………………………………………………………….426
MDA 19…………………………………………………………………………………………427
MEIGE’S SYNDROME………………………………………………………………………………………………..428
MEMORY- see IQ
MENIERE’S SYNDROME……………………………………………………………………………………………428
MENINGITIS………………………………………………………………………………………………………………428
MENOPAUSE……………………………………………………………………………………………………………..428
MENTAL DISORDERS – see SCHIZOPHRENIA
METHODS OF USE – BREATH STRIPS……………………………………………………429
METHODS OF USE- CAPSULES………………………………………………………………………………..430
METHODS OF USE – DECARBOXYLATION………………………………………………430
678METHODS OF USE- E-CIGARETTES……………………………………………………..430
METHODS OF USE- EDIBLES…………………………………………………………………………………..431
METHODS OF USE- EDIBLES – BEVERAGES…………………………………………………………..432
METHODS OF USE- EDIBLES – FOODS…………………………………………………………………..433
METHODS OF USE – INHALERS…………………………………………………………..434
METHODS OF USE – INJECTION………………………………………………………………………………..435
METHODS OF USE – NASAL SPRAYS………………………………………………………………………..436
METHODS OF USE – RSO / RICK SIMPSON‘S OIL………………………………………..436
METHODS OF USE – SMOKING…………………………………………………………………………………437
METHODS OF USE – SUPPOSITORIES……………………………………………………………………….441
METHODS OF USE – TINCTURES………………………………………………………………………………441
METHODS OF USE – TOPICAL OINTMENTS……………………………………………………………..442
METHODS OF USE -TRANSDERMAL PATCH……………………………………………………………444
METHODS OF USE – VAPORIZERS……………………………………………………………………………444
METHODS OF USE- VARIOUS…………………………………………………………………………………..446
MIGRAINE/ HEADACHE……………………………………………………………………………………………447
MISCELANEOUS STUFF…………………………………………………………………………………………….448
MORNING SICKNESS………………………………………………………………………………………………..454
MORTALITY RATES………………………………………………………………………………………………….455
MOTION SICKNESS……………………………………………………………………………………………………456
MRSA/ METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS……………………………..457
MULTIPLE SCLEROSIS/ MS……………………………………………………………………………………….458
MUSCULAR DYSTROPHY/ MD………………………………………………………………………………….469
MUSCLE RELAXANT…………………………………………………………………………………………………469
NABILONE…………………………………………………………………………………………………………………470
NAIL-PATELLA SYNDROME………………………………………………………………..475
NAUSEA…………………………………………………………………………………………………………………….475
NEURONS/ BRAIN CELLS………………………………………………………………………………………….481
NEUROPATHIC PAIN…………………………………………………………………………………………………487
NEUROPROTECTANT………………………………………………………………………………………………..492
NIEMANN-PICK DISEASE………………………………………………………………………………………….497
NIGHT SWEATS……………………………………………………………………………….498
NUTRITION – GENERAL…………………………………………………………………………………………….498
NUTRITION – HEMP SEED…………………………………………………………………………………………499
NUTRITION – HEMP SEED OIL…………………………………………………………………………………..502
O-1602………………………………………………………………………………………….504
O-1966………………………………………………………………………………………….504
OBESITY…………………………………………………………………………………………………………………….505
OBSESSIVE COMPULSIVE DISORDER………………………………………………………………………510
OMEGA-3/ CB1 CONNECTION ………………………………………………………………511
679ORGAN TRANSPLANTS………………………………………………………………………………………512
OSTEOPOROSIS/ BONES…………………………………………………………………………………………..514
OVERDOSES……………………………………………………………………………………………………………..517
OVERVIEWS……………………………………………………………………………………………………………..517
PAIN…………………………………………………………………………………………………………………………..519
PANCREATITIS………………………………………………………………………………………………………….527
PERINATAL HYPOXIC-ISCHEMIC INJURY……………………………………………….528
PARKINSON’S DISEASE…………………………………………………………………………………………….529
PATENTS RELATED TO CANNABIS………………………………………………………………………….532
PEA – PALMITOYLETHANOLAMIDE………………………………………………………537
PHARC…………………………………………………………………………………………538
PHYTOCANNABINOIDS / PLANT EXTRACTS…………………………………………………………..539
POISONING – ORGANOPHOSPHATE……………………………………………………….544
POISONING – PARAQUAT…………………………………………………………………..544
POST-OPERATIVE PAIN…………………………………………………………………………………………….545
POST TRAUMATIC STRESS DISORDER/ PTSD………………………………………………………….546
PRADER WILLI SYNDROME………………………………………………………………..549
PREGNANCY/ PRENATAL EXPOSURE……………………………………………………………………..550
PRIONS………………………………………………………………………………………………………………………555
PROXIMAL MYOTONIC MYOPATHY / PROMM……………………………………………………….556
PRURITIS (chronic itch)…………………………………………………………………………………………..556
PSORIASIS…………………………………………………………………………………………………………………558
QUITTING CANNABIS……………………………………………………………………….559
QUITTING OTHER DRUGS…………………………………………………………………………………………560
RADIATION-INDUCED NAUSEA……………………………………………………………………………….563
RADIATION SICKNESS………………………………………………………………………564
REFLEX SYMPATHETIC DYSTROPHY……………………………………………………564
RESTLESS LEG SYNDROME……………………………………………………………………………………..564
RETINITIS PIGMENTOSA……………………………………………………………………565
RIMONABANT…………………………………………………………………………………………………………..565
R(+)-METHANANANDAMIDE…………………………………………………………………………………569
RWJ- 400065……………………………………………………………………………………………………………… 571
SAFETY AS A MEDICINE…………………………………………………………………………………………..571
SAFETY-ADULTERANTS/ CONTAMINANTS…………………………………………………………….573
680SATIVEX………………………………………………………………………………………………………………575
SCHIZOPHRENIA/ MENTAL DISORDERS…………………………………………………………………578
SCLERODERMA………………………………………………………………………………………………………..585
SEPTIC SHOCK………………………………………………………………………………………………………….586
SICKLE CELL DISEASE……………………………………………………………………………………………..587
SINUSITIS……………………………………………………………………………………………………….. ………587
SLEEPING SICKNESS/ TRYPANOSOMIASIS………………………………………………588
SLEEP MODULATION………………………………………………………………………………………………..588
SMALLPOX…………………………………………………………………………………….590
SMELL / ODOR DETECTION…………………………………………………………………590
SMOKED CANNABIS AS A MEDICATION…………………………………………………………………591
SOCIAL ADJUSTMENT/ BEHAVIOR………………………………………………………………………….595
SPASTICITY……………………………………………………………………………………………………. ………597
SPICE……………………………………………………………………………………………601
SPINAL CORD INJURY………………………………………………………………………………………………603
SPLEEN…………………………………………………………………………………………606
STEM CELLS…………………………………………………………………………………..606
STRESS…………………………………………………………………………………………607
STORAGE………………………………………………………………………………………608
STROKE……………………………………………………………………………………………………………………..608
TAK SERIES…………………………………………………………………………………..612
TASTE………………………………………………………………………………………….612
TAXONOMY/ GENETICS OF CANNABIS…………………………………………………………………..613
TEA AS MEDICINE…………………………………………………………………………………………………….617
TEETH /DENTISTRY…………………………………………………………………………………………………..617
THC/ TETRAHYDROCANNABINOL…………………………………………………………………………..618
THC ACID/ THCA……………………………………………………………………………………………………….636
TETRAHYDROCANNABINOL-HEMISUCCINATE / THC-HS……………………………………..637
TETRAHYDROCANNABOVARIN/ THCV…………………………………………………………………..638
TIME PERCEPTION……………………………………………………………………………640
TINNITUS- also see HEARING ………………………………………………………………………………..640
TOBACCO VS CANNABIS………………………………………………………………………………………….641
TOLERANCE………………………………………………………………………………………………………………645
TOURETTE’S SYNDROME…………………………………………………………………………………………646
TRICHOTILLOMANIA………………………………………………………………………..648
TUBERCULOSIS…………………………………………………………………………………………………………648
ULCERATIVE COLITIS – see COLITIS, also BOWEL DISORDERS
URB – 597/ KDS-4103…………………………………………………………………………………………………649
URB – 754…………………………………………………………………………………………………………………..651
URB – 973…………………………………………………………………………………………………………………..651
681VAPORIZERS – see METHODS OF USE- VAPORIZERS
VETERINARY USE/ ANIMALS…………………………………………………………………………………..652
VISION……………………………………………………………………………………………………………………….654
WILSON’S DISEASE………………………………………………………………………………………………….657
WIN 55,212-2………………………………………………………………………………………………………………657
WITHDRAWAL SYNDROME……………………………………………………………………………………..669
WOUNDS/ INJURIES…………………………………………………………………………………………………..670
YOUNG ADULTS – see CHILDREN/YOUNG ADULTS
The Cannabis Cure Restoration Foundation 